Certara Inc
XNAS:CERT
| Market Cap (Intraday) | 1.37B |
| Current PE | 125.64 |
| Forward PE | 18.65 |
| 2yr Forward PE | 15.6 |
| 10-Day MA | $9.03 |
| 50-Day MA | $10.62 |
| 200-Day MA | $11.16 |
Certara Inc Stock, XNAS:CERT
4 Radnor Corporate Center, Suite 350, Radnor, Pennsylvania 19087
United States of America
Phone: +1.415.237.8772
Number of Employees: 1546
Description
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.